#IQVIA
And IQVIA is investing in the next generation too. Through apprenticeships and partnerships with local schools, it’s helping young people discover career opportunities in science, technology and research.
November 3, 2026 at 7:02 PM
Our Head of Partnerships and Involvement,
@sarahtilsed.bsky.social is speaking at the IQVIA Annual Summit, Ready or Not: Delivering the Next Generation of Population Health next week!
Take a look at the agenda: buff.ly/QeO6Qxr
October 30, 2026 at 8:26 AM
🔬 World-leading science, skilled jobs and global impact, all from the Livingston constituency.

I recently visited IQVIA Laboratories at Alba Campus to see how the expertise here in Livingston is helping advance the development of new medicines and treatments around the world.
November 3, 2026 at 7:02 PM
The Livingston constituency has a proud track record in science, innovation and industry. Businesses like IQVIA demonstrate the strength of our local talent and the opportunities we have to attract investment, create skilled jobs and build on our position as a centre for life sciences.
November 3, 2026 at 7:02 PM
The IQVIA analysis seeks to use the rejection rate data to make a case that patient access has been compromised by the plan. Limited access to drugs is baked into Medicare Part D from its programtic start in 2006, insurers are there to keep cost growth low by denying care.
November 1, 2026 at 12:05 PM
Study Start up Specialist, IQVIA Biotech - São Paulo, Brazil Job educativ.net/jobs/job/67705...
October 30, 2026 at 10:32 PM
Study Start up Specialist, IQVIA Biotech - São Paulo, Brazil Job educativ.net/jobs/job/67705...
October 30, 2026 at 10:32 PM
At its flagship laboratory facility, IQVIA provides specialist testing, analysis and scientific services that support pharmaceutical and biotechnology companies conducting medical research and clinical trials across the globe.
November 3, 2026 at 7:02 PM
The blog post by IQVIA is pretty entertaining explicit, “Expectations for Medicare drug price negotiation to improve patient access have yet to come to fruition.”
November 1, 2026 at 12:05 PM
Ms. Chippo then drops a reference to an “IQVIA analysis” that found for selection of drugs that just under one in four Plan D participants had their first prescription request rejected.
November 1, 2026 at 12:05 PM
Clinical Trial Manager II, IQVIA Biotech - Mexico City, Mexico Job educativ.net/jobs/job/67651...
October 29, 2026 at 9:45 PM
Clinical Trial Manager II, IQVIA Biotech - Mexico City, Mexico Job educativ.net/jobs/job/67651...
October 29, 2026 at 9:33 PM
What she didn’t mention is that figure falls to less than one in sixteen 30 days out but we will come back to IQVIA in a moment, lets stick with her argument.
November 1, 2026 at 12:05 PM
Clinical Trial Manager II, IQVIA Biotech - Mexico City, Mexico Job educativ.net/jobs/job/67651...
October 29, 2026 at 9:45 PM
Clinical Trial Manager II, IQVIA Biotech - Mexico City, Mexico Job educativ.net/jobs/job/67651...
October 29, 2026 at 9:33 PM
Let’s return to the IQVIA analysis, It has a disclaimer at the bottom that reads “This report and the analyses used were sponsored by the Pharmaceutical Research and Manufacturers of America (PhRMA).” www.iqvia.com/locations/un...
Rejection Rates Unchanged by MFP Drug Coverage Requirement
<ul style="margin-left: 30px;"> <li><em>In Q1 2026, after the coverage requirement for IPAY 2026-selected drugs took effect, nearly a quarter (24%) of first fill attempts for these drugs were init...
www.iqvia.com
November 1, 2026 at 12:05 PM
Head, Industry Partnerships, IQVIA Digital - New York, New York, United States of America Job educativ.net/jobs/job/67592...
October 28, 2026 at 10:05 PM
Head, Industry Partnerships, IQVIA Digital - New York, New York, United States of America Job educativ.net/jobs/job/67592...
October 28, 2026 at 10:05 PM